145 related articles for article (PubMed ID: 35347088)
1. Lung Infection Affects Access to Treatment and Short-Term Outcome in Patients With Severe Alcohol-Related Hepatitis Treated With Corticosteroids.
Ntandja Wandji LC; Ningarhari M; Lemaître E; Khaldi M; Saffers P; Lollivier J; Lassailly G; Dharancy S; Mathurin P; Louvet A
Am J Gastroenterol; 2022 Jul; 117(7):1097-1105. PubMed ID: 35347088
[TBL] [Abstract][Full Text] [Related]
2. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
Louvet A; Wartel F; Castel H; Dharancy S; Hollebecque A; Canva-Delcambre V; Deltenre P; Mathurin P
Gastroenterology; 2009 Aug; 137(2):541-8. PubMed ID: 19445945
[TBL] [Abstract][Full Text] [Related]
3. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
Trépo E; Goossens N; Fujiwara N; Song WM; Colaprico A; Marot A; Spahr L; Demetter P; Sempoux C; Im GY; Saldarriaga J; Gustot T; Devière J; Thung SN; Minsart C; Sersté T; Bontempi G; Abdelrahman K; Henrion J; Degré D; Lucidi V; Rubbia-Brandt L; Nair VD; Moreno C; Deltenre P; Hoshida Y; Franchimont D
Gastroenterology; 2018 Mar; 154(4):965-975. PubMed ID: 29158192
[TBL] [Abstract][Full Text] [Related]
4. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.
Louvet A; Labreuche J; Artru F; Boursier J; Kim DJ; O'Grady J; Trépo E; Nahon P; Ganne-Carrié N; Naveau S; Diaz E; Gustot T; Lassailly G; Cannesson-Leroy A; Canva-Delcambre V; Dharancy S; Park SH; Moreno C; Morgan TR; Duhamel A; Mathurin P
Gastroenterology; 2015 Aug; 149(2):398-406.e8; quiz e16-7. PubMed ID: 25935634
[TBL] [Abstract][Full Text] [Related]
5. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.
Arab JP; Díaz LA; Baeza N; Idalsoaga F; Fuentes-López E; Arnold J; Ramírez CA; Morales-Arraez D; Ventura-Cots M; Alvarado-Tapias E; Zhang W; Clark V; Simonetto D; Ahn JC; Buryska S; Mehta TI; Stefanescu H; Horhat A; Bumbu A; Dunn W; Attar B; Agrawal R; Haque ZS; Majeed M; Cabezas J; García-Carrera I; Parker R; Cuyàs B; Poca M; Soriano G; Sarin SK; Maiwall R; Jalal PK; Abdulsada S; Higuera-de la Tijera MF; Kulkarni AV; Rao PN; Guerra Salazar P; Skladaný L; Bystrianska N; Prado V; Clemente-Sanchez A; Rincón D; Haider T; Chacko KR; Cairo F; de Sousa Coelho M; Romero GA; Pollarsky FD; Restrepo JC; Castro-Sanchez S; Toro LG; Yaquich P; Mendizabal M; Garrido ML; Narvaez A; Bessone F; Marcelo JS; Piombino D; Dirchwolf M; Arancibia JP; Altamirano J; Kim W; Araujo RC; Duarte-Rojo A; Vargas V; Rautou PE; Issoufaly T; Zamarripa F; Torre A; Lucey MR; Mathurin P; Louvet A; García-Tsao G; González JA; Verna E; Brown RS; Roblero JP; Abraldes JG; Arrese M; Shah VH; Kamath PS; Singal AK; Bataller R
J Hepatol; 2021 Nov; 75(5):1026-1033. PubMed ID: 34166722
[TBL] [Abstract][Full Text] [Related]
6. Model of disease severity in alcoholic hepatitis and novel prognostic insights.
Enciu VT; Ologeanu PM; Călin-Necula AM; Moldoveanu AC; Oprea-Călin G; Fierbinţeanu-Braticevici C
Rom J Intern Med; 2024 Jun; 62(2):194-202. PubMed ID: 38180800
[TBL] [Abstract][Full Text] [Related]
7. Invasive aspergillosis in patients with severe alcoholic hepatitis.
Gustot T; Maillart E; Bocci M; Surin R; Trépo E; Degré D; Lucidi V; Taccone FS; Delforge ML; Vincent JL; Donckier V; Jacobs F; Moreno C
J Hepatol; 2014 Feb; 60(2):267-74. PubMed ID: 24055548
[TBL] [Abstract][Full Text] [Related]
8. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.
Daswani R; Kumar A; Anikhindi SA; Sharma P; Singla V; Bansal N; Arora A
Indian J Gastroenterol; 2018 Mar; 37(2):141-152. PubMed ID: 29704174
[TBL] [Abstract][Full Text] [Related]
9. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
Louvet A; Naveau S; Abdelnour M; Ramond MJ; Diaz E; Fartoux L; Dharancy S; Texier F; Hollebecque A; Serfaty L; Boleslawski E; Deltenre P; Canva V; Pruvot FR; Mathurin P
Hepatology; 2007 Jun; 45(6):1348-54. PubMed ID: 17518367
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials.
Hmoud BS; Patel K; Bataller R; Singal AK
Liver Int; 2016 May; 36(5):721-8. PubMed ID: 26279269
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-monocyte/macrophage apheresis for steroid-nonresponsive or steroid-intolerant severe alcohol-associated hepatitis: A pilot study.
Kasuga R; Chu PS; Taniki N; Yoshida A; Morikawa R; Tabuchi T; Noguchi F; Yamataka K; Nakadai Y; Kondo M; Ebinuma H; Kanai T; Nakamoto N
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285891
[TBL] [Abstract][Full Text] [Related]
12. Corticosteroids or non-corticosteroids: a fresh perspective on alcoholic hepatitis treatment.
Wang F; Wang BY
Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):458-64. PubMed ID: 21947718
[TBL] [Abstract][Full Text] [Related]
13. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver Disease.
Otero Sanchez L; Karakike E; Njimi H; Putignano A; Degré D; Hites M; Jacobs F; Moreno C; Trepo E; Gustot T
Hepatology; 2021 Nov; 74(5):2714-2724. PubMed ID: 34046927
[TBL] [Abstract][Full Text] [Related]
14. Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes.
Singeap AM; Minea H; Petrea O; Robea MA; Balmuș IM; Duta R; Ilie OD; Cimpoesu CD; Stanciu C; Trifan A
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399598
[No Abstract] [Full Text] [Related]
15. A prognostic evaluation and management of alcoholic hepatitis.
Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.
Rudler M; Mouri S; Charlotte F; Lebray P; Capocci R; Benosman H; Poynard T; Thabut D
J Hepatol; 2015 Apr; 62(4):816-21. PubMed ID: 25450199
[TBL] [Abstract][Full Text] [Related]
17. Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis.
Deltenre P; Trépo E; Fujiwara N; Goossens N; Marot A; Dubois M; Spahr L; Henrion J; Moreno C; Hoshida Y
Liver Int; 2020 Mar; 40(3):565-570. PubMed ID: 31568650
[TBL] [Abstract][Full Text] [Related]
18. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
Sharma P; Kumar A; Sharma BC; Sarin SK
J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
20. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.
Papastergiou V; Tsochatzis EA; Pieri G; Thalassinos E; Dhar A; Bruno S; Karatapanis S; Luong TV; O'Beirne J; Patch D; Thorburn D; Burroughs AK
Aliment Pharmacol Ther; 2014 Apr; 39(7):721-32. PubMed ID: 24612165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
